23
Cooperative Oncology Group. Ann Oncol 16(6): 972-980,
6/2005.
11. Du Pen SL, Du Pen AR, Polissar N, Hansberry J, Kraybill BM,
Stillman M, Panke J, Everly R, Syrjala K. Implementing
guidelines for cancer pain management: results of a
randomized controlled clinical trial. J Clin Oncol 17(1): 361-
370, 1/1999.
12. Elliott BA, Elliott TE, Murray DM, Braun BL, Johnson KM. Patients
and family members: the role of knowledge and attitudes in
cancer pain. J Pain Symptom Manage 12(4): 209-220,
10/1996.
13. Esnaola NF, Cantor SB, Johnson ML, Mirza AN, Miller AR, Curley
SA, Crane CH, Cleeland CS, Janjan NA, Skibber JM. Pain and
quality of life after treatment in patients with locally recurrent
rectal cancer. J Clin Oncol 20(21): 4361-4367, 11/2002.
14. Ferrell BR, Grant MM, Funk BM, Otis-Green SA, Garcia NJ.
Quality of life in breast cancer survivors: implications for
developing support services. Oncol Nurs Forum 25(5): 887-895,
6/1998.
15. Gabrail NY, Dvergsten C, Ahdieh H. Establishing the dosage
equivalency of oxymorphone extended release and
oxycodone controlled release in patients with cancer pain: a
randomized controlled study. Curr Med Res Opin 20(6): 911-
918, 6/2004.
16. Gulluoglu BM, Cingi A, Cakir T, Gercek A, Barlas A, Eti Z.
Factors related to post-treatment chronic pain in breast
cancer survivors: the interference of pain with life functions.
Int J Fertil Womens Med 51(2): 75-82, 3/2006.
17. Holtan A, Kongsgaard UE, Ohnstad HO. [Cancer pain in
hospitalized patients]. Tidsskr Nor Laegeforen 125(4): 416-418,
2/2005.
18. Holtan A, Kongsgaard UE, Haugen DF. Episodic pain in
hospitalized cancer patients. European Journal of Pain
10(Supplement 1): S247, 9/2006.
24
19. Hsu TH, Lu MS, Tsou TS, Lin CC. The relationship of pain,
uncertainty, and hope in Taiwanese lung cancer patients. J
Pain Symptom Manage 26(3): 835-842, 9/2003.
20. Huang HY, Wilkie DJ, Chapman CR, Ting LL. Pain trajectory of
Taiwanese with nasopharyngeal carcinoma over the course
of radiation therapy. J Pain Symptom Manage 25(3): 247-255,
3/2003.
21. Hwang SS, Chang VT, Fairclough DL, Kasimis B. Development
of a cancer pain prognostic scale. J Pain Symptom Manage
24(4): 366-378, 10/2002.
22. Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain
characteristics and responses to treatment at a VA medical
center. Pain 101(1-2): 55-64, 1/2003.
23. Kashikar-Zuck S, Keefe FJ, Kornguth P, Beaupre P, Holzberg A,
Delong D. Pain coping and the pain experience during
mammography: a preliminary study. Pain 73(2): 165-172,
11/1997.
24. Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T,
Fayers P, Fougner B, Kaasa S. Routine drug monitoring of
serum concentrations of morphine, morphine-3-glucuronide
and morphine-6-glucuronide do not predict clinical
observations in cancer patients. Palliat Med 17(8): 679-687,
12/2003.
25. Konski A, DeSilvio M, Hartsell W, Watkins-Bruner D, Coyne J,
Scarantino C, JanJan N. Continuing evidence for poorer
treatment outcomes for single male patients: Retreatment
data from RTOG 97-14. Int J Radiat Oncol Biol Phys 66(1): 229-
233, 9/2006.
26. Lai YH, Guo SL, Keefe FJ, Tsai SL, Chien CC, Sung YC, Chen
ML. Effects of brief pain education on hospitalized cancer
patients with moderate to severe pain. Support Care Cancer
12(9): 645-652, 9/2004.
27. Leppert W. Controlled release dihydrocodeine and tramadol
in cancer pain treatment-Polish experience. Eur J Pain
10(Supplement 1): S147, 9/2006.
